ATE284683T1 - Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung - Google Patents
Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmungInfo
- Publication number
- ATE284683T1 ATE284683T1 AT97941381T AT97941381T ATE284683T1 AT E284683 T1 ATE284683 T1 AT E284683T1 AT 97941381 T AT97941381 T AT 97941381T AT 97941381 T AT97941381 T AT 97941381T AT E284683 T1 ATE284683 T1 AT E284683T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- isovaleramide
- concussions
- headaches
- epilepsy
- Prior art date
Links
- SANOUVWGPVYVAV-UHFFFAOYSA-N isovaleramide Chemical compound CC(C)CC(N)=O SANOUVWGPVYVAV-UHFFFAOYSA-N 0.000 title abstract 2
- 206010019233 Headaches Diseases 0.000 title 1
- 206010041415 Spastic paralysis Diseases 0.000 title 1
- 206010015037 epilepsy Diseases 0.000 title 1
- 230000001575 pathological effect Effects 0.000 abstract 2
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 abstract 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 208000008238 Muscle Spasticity Diseases 0.000 abstract 1
- 235000013832 Valeriana officinalis Nutrition 0.000 abstract 1
- 244000126014 Valeriana officinalis Species 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000065 noncytotoxic Toxicity 0.000 abstract 1
- 230000002020 noncytotoxic effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 208000018198 spasticity Diseases 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- 235000016788 valerian Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Psychology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2505096P | 1996-08-30 | 1996-08-30 | |
| PCT/US1997/015272 WO1998008498A1 (en) | 1996-08-30 | 1997-08-29 | Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE284683T1 true ATE284683T1 (de) | 2005-01-15 |
Family
ID=21823778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97941381T ATE284683T1 (de) | 1996-08-30 | 1997-08-29 | Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0938304B1 (de) |
| JP (1) | JP2000504035A (de) |
| KR (1) | KR100594400B1 (de) |
| CN (2) | CN1152677C (de) |
| AT (1) | ATE284683T1 (de) |
| AU (1) | AU728765B2 (de) |
| BR (1) | BR9713188A (de) |
| CA (1) | CA2264577A1 (de) |
| DE (1) | DE69731968T2 (de) |
| DK (1) | DK0938304T3 (de) |
| ES (1) | ES2235251T3 (de) |
| IL (1) | IL128724A (de) |
| PT (1) | PT938304E (de) |
| RU (1) | RU2232016C2 (de) |
| WO (1) | WO1998008498A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6589994B1 (en) * | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
| AU2003204485B2 (en) * | 1998-03-04 | 2006-06-08 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
| AU2894599A (en) * | 1998-03-04 | 1999-09-20 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
| EP1576962A1 (de) * | 1998-03-04 | 2005-09-21 | Nps Pharmaceuticals, Inc. | Zusammensetzungen enthaltend Isovalerianamide zusammen mit ibuprofen |
| US6383527B1 (en) * | 1999-03-04 | 2002-05-07 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID |
| US6346283B1 (en) | 1999-03-26 | 2002-02-12 | Ancile Pharmaceuticals | Use of valeriana for the treatment of restless leg syndrome and related disorders |
| US7235258B1 (en) | 1999-10-19 | 2007-06-26 | Nps Pharmaceuticals, Inc. | Sustained-release formulations for treating CNS-mediated disorders |
| AU780505B2 (en) * | 1999-10-19 | 2005-03-24 | Nps Pharmaceuticals, Inc. | Sustained-release formulations for treating CNS-mediated disorders |
| IL154470A0 (en) * | 2000-08-17 | 2003-09-17 | Teva Pharma | Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders |
| CA2437353A1 (en) * | 2001-02-08 | 2002-08-15 | Nps Pharmaceuticals, Inc. | Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| WO2003063605A1 (en) * | 2002-02-01 | 2003-08-07 | Eugene Science Inc. | Chewing gum composition containing plant sterol for decrease of flood cholesterol levels and prevention of periodontal disease |
| WO2006012603A2 (en) * | 2004-07-22 | 2006-02-02 | Nps Pharmaceuticals, Inc. | Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
| DE102006062264A1 (de) * | 2006-12-22 | 2008-06-26 | Joh. Barth & Sohn Gmbh & Co. Kg | Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen |
| RU2460534C1 (ru) * | 2011-04-15 | 2012-09-10 | Учреждение Российская академия наук Сибирское отделение (СО РАН) Институт общей и экспериментальной биологии (ИОЭБ СО РАН) | Способ получения средства, обладающего анксиолитической активностью |
| CN103565959B (zh) * | 2013-11-06 | 2015-04-08 | 李传平 | 一种治疗精神分裂症的汤剂 |
| CN103961341B (zh) * | 2014-05-30 | 2015-12-02 | 杨献华 | 一种治疗偏头痛的药物组合物及其应用 |
| WO2017150903A1 (en) * | 2016-02-29 | 2017-09-08 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
| KR102333460B1 (ko) * | 2016-11-15 | 2021-12-15 | 경희대학교 산학협력단 | 쥐오줌풀 추출물을 유효성분으로 포함하는 측두엽 뇌전증 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617555C3 (de) * | 1966-04-19 | 1974-09-19 | Kali-Chemie Ag, 3000 Hannover | Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten |
| DE2230626B2 (de) * | 1972-06-22 | 1978-07-20 | Roland Dr. 7967 Bad Waldsee Schaette | Baldrianpräparat |
| US5506268A (en) * | 1993-06-11 | 1996-04-09 | Nps Pharmaceuticals, Inc. | Use of isovaleramide as a mild anxiolytic and sedative agent |
-
1997
- 1997-08-29 AT AT97941381T patent/ATE284683T1/de not_active IP Right Cessation
- 1997-08-29 CN CNB971992576A patent/CN1152677C/zh not_active Expired - Fee Related
- 1997-08-29 WO PCT/US1997/015272 patent/WO1998008498A1/en not_active Ceased
- 1997-08-29 IL IL12872497A patent/IL128724A/xx not_active IP Right Cessation
- 1997-08-29 ES ES97941381T patent/ES2235251T3/es not_active Expired - Lifetime
- 1997-08-29 PT PT97941381T patent/PT938304E/pt unknown
- 1997-08-29 RU RU99106406/14A patent/RU2232016C2/ru not_active IP Right Cessation
- 1997-08-29 EP EP97941381A patent/EP0938304B1/de not_active Expired - Lifetime
- 1997-08-29 CA CA002264577A patent/CA2264577A1/en not_active Abandoned
- 1997-08-29 KR KR1019997001716A patent/KR100594400B1/ko not_active Expired - Fee Related
- 1997-08-29 CN CNA2004100342927A patent/CN1531924A/zh active Pending
- 1997-08-29 AU AU43302/97A patent/AU728765B2/en not_active Ceased
- 1997-08-29 BR BR9713188-1A patent/BR9713188A/pt not_active Application Discontinuation
- 1997-08-29 DE DE69731968T patent/DE69731968T2/de not_active Expired - Fee Related
- 1997-08-29 DK DK97941381T patent/DK0938304T3/da active
- 1997-08-29 JP JP10511976A patent/JP2000504035A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998008498A1 (en) | 1998-03-05 |
| EP0938304B1 (de) | 2004-12-15 |
| IL128724A (en) | 2003-05-29 |
| JP2000504035A (ja) | 2000-04-04 |
| IL128724A0 (en) | 2000-01-31 |
| CN1235541A (zh) | 1999-11-17 |
| CN1531924A (zh) | 2004-09-29 |
| CN1152677C (zh) | 2004-06-09 |
| EP0938304A1 (de) | 1999-09-01 |
| AU4330297A (en) | 1998-03-19 |
| BR9713188A (pt) | 1999-11-03 |
| PT938304E (pt) | 2005-04-29 |
| DE69731968D1 (de) | 2005-01-20 |
| KR20000038194A (ko) | 2000-07-05 |
| RU2232016C2 (ru) | 2004-07-10 |
| HK1023725A1 (en) | 2000-09-22 |
| DK0938304T3 (da) | 2005-03-14 |
| DE69731968T2 (de) | 2005-12-22 |
| ES2235251T3 (es) | 2005-07-01 |
| AU728765B2 (en) | 2001-01-18 |
| KR100594400B1 (ko) | 2006-07-03 |
| CA2264577A1 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE284683T1 (de) | Isovaleramid zur behandlung von schüttelkrämpfen, epilepsie, kopfschmerzen und spastischer lähmung | |
| WO2000051586A3 (en) | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound | |
| SI0725779T1 (de) | ||
| IT1304152B1 (it) | Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato | |
| BG102733A (en) | New substituted cyclic amino acids as pharmaceutical forms | |
| DE69706566D1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| MY114889A (en) | 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity | |
| UA39189C2 (uk) | Бактерицидний засіб, спосіб боротьби з грибковими хворобами рослин та захисту рослин від ураження грибками | |
| YU58800A (sh) | Primena derivata fumarne kiseline u transplantacionoj medicini | |
| NZ326555A (en) | Inhibitors of interleukin-1beta converting enzyme (ICE) | |
| NZ326874A (en) | 6-phenylpyridyl-2-amine derivatives | |
| ATE229533T1 (de) | Nitrat-salze als arzneimittel | |
| IL111293A0 (en) | Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia | |
| BG103096A (en) | Thrombin inhibitors | |
| IL109982A0 (en) | Pharmaceutical compositions containing isovaleramide and methods for the preparation thereof | |
| UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
| ATE237610T1 (de) | Substituierte dimere carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| BG102660A (en) | Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders | |
| BG105014A (en) | Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres | |
| IL106288A0 (en) | Skin regenerating cosmetic compositions | |
| AU2287197A (en) | Heterocyclic compounds and their preparation and use | |
| ATE275953T1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| IT1270660B (it) | Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi | |
| WO1997019669A3 (en) | Heterocyclic compounds and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0938304 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |